Search research articles
Contact Us
Filters
Showing results (11-20 of 55) with videos related to
Page
of 6
Sort By:
International Journal of Dermatology
|
October 24, 2017
A 71-year-old man with a hemorrhagic vesicular eruption
Claire E Hamilton, Brett A King, Shawn E Cowper, et al.
Investigational New Drugs
|
September 8, 2006
Phase II trial of nolatrexed dihydrochloride [Thymitaq, AG 337] in patients with advanced hepatocellular carcinoma
Minaxi Jhawer, Lee Rosen, Janet Dancey, et al.
Cancer Chemotherapy and Pharmacology
|
November 12, 2010
Phase 1/pharmacology study of intraperitoneal topotecan alone and with cisplatin: potential for consolidation in ovarian cancer
Eleni Andreopoulou, Thomas Chen, Leonard Liebes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 30, 2003
Randomized phase II comparison of dose-intense gemcitabine: thirty-minute infusion and fixed dose rate infusion in patients with pancreatic adenocarcinoma
Margaret Tempero, William Plunkett, Veronique Ruiz Van Haperen, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
April 27, 2023
Body weight loss as a prognostic and predictive factor in previously treated patients with metastatic gastric cancer: post hoc analyses of the randomized phase III TAGS trial
Michele Ghidini, Howard Hochster, Toshihiko Doi, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
May 7, 2002
Neoadjuvant chemotherapy with CPT-11 and cisplatin downstages locally advanced gastric cancer
Elliot Newman, Stuart G Marcus, Milan Potmesil, et al.
Gynecologic Oncology
|
January 15, 2008
Tolerance and activity of oxaliplatin with protracted topotecan infusion in patients with previously treated ovarian cancer. A phase I study
Howard Hochster, Thomas T Chen, Janice M Lu, et al.
Seminars in Oncology
|
January 10, 2006
Neoadjuvant chemotherapy, surgery, and adjuvant intraperitoneal chemotherapy in patients with locally advanced gastric or gastroesophageal junction carcinoma: a phase II study
Elliot Newman, Milan Potmesil, Theresa Ryan, et al.
Journal of the National Cancer Institute
|
June 8, 2026
Diversity, equity, and inclusion as scientific rigor: progress during challenging times
Leticia M Nogueira, Matthew F Hudson, Barbara Pistilli, et al.
JNCI Cancer Spectrum
|
June 8, 2026
Diversity, equity, and inclusion as scientific rigor: progress during challenging times
Leticia M Nogueira, Matthew F Hudson, Barbara Pistilli, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 55) with videos related to
Sort By:
Page
of 6
International Journal of Dermatology
|
October 24, 2017
A 71-year-old man with a hemorrhagic vesicular eruption
Claire E Hamilton, Brett A King, Shawn E Cowper, et al.
Investigational New Drugs
|
September 8, 2006
Phase II trial of nolatrexed dihydrochloride [Thymitaq, AG 337] in patients with advanced hepatocellular carcinoma
Minaxi Jhawer, Lee Rosen, Janet Dancey, et al.
Cancer Chemotherapy and Pharmacology
|
November 12, 2010
Phase 1/pharmacology study of intraperitoneal topotecan alone and with cisplatin: potential for consolidation in ovarian cancer
Eleni Andreopoulou, Thomas Chen, Leonard Liebes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 30, 2003
Randomized phase II comparison of dose-intense gemcitabine: thirty-minute infusion and fixed dose rate infusion in patients with pancreatic adenocarcinoma
Margaret Tempero, William Plunkett, Veronique Ruiz Van Haperen, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
April 27, 2023
Body weight loss as a prognostic and predictive factor in previously treated patients with metastatic gastric cancer: post hoc analyses of the randomized phase III TAGS trial
Michele Ghidini, Howard Hochster, Toshihiko Doi, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
May 7, 2002
Neoadjuvant chemotherapy with CPT-11 and cisplatin downstages locally advanced gastric cancer
Elliot Newman, Stuart G Marcus, Milan Potmesil, et al.
Gynecologic Oncology
|
January 15, 2008
Tolerance and activity of oxaliplatin with protracted topotecan infusion in patients with previously treated ovarian cancer. A phase I study
Howard Hochster, Thomas T Chen, Janice M Lu, et al.
Seminars in Oncology
|
January 10, 2006
Neoadjuvant chemotherapy, surgery, and adjuvant intraperitoneal chemotherapy in patients with locally advanced gastric or gastroesophageal junction carcinoma: a phase II study
Elliot Newman, Milan Potmesil, Theresa Ryan, et al.
Journal of the National Cancer Institute
|
June 8, 2026
Diversity, equity, and inclusion as scientific rigor: progress during challenging times
Leticia M Nogueira, Matthew F Hudson, Barbara Pistilli, et al.
JNCI Cancer Spectrum
|
June 8, 2026
Diversity, equity, and inclusion as scientific rigor: progress during challenging times
Leticia M Nogueira, Matthew F Hudson, Barbara Pistilli, et al.
Page
of 6